Cardiovascular Safety of Romosozumab Versus Other Anti-Osteoporosis Medications in Patients with Osteoporosis: A Nationwide Health Insurance Claims Database Study in Japan
- DOI
- 10.1007/s00223-026-01572-0
- Published
- 2026-07-09
- Container
- Calcified Tissue International
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s00223-026-01572-0,
title = {Cardiovascular Safety of Romosozumab Versus Other Anti-Osteoporosis Medications in Patients with Osteoporosis: A Nationwide Health Insurance Claims Database Study in Japan},
author = {Yuki Fujita and Katsuyasu Kouda and Kenji Fujimori and Nobukazu Okimoto and Shinichi Nakatoh and Junko Tamaki and Shigeyuki Ishii and Sumito Ogawa and Masayuki Iki},
year = {2026},
journal = {Calcified Tissue International},
doi = {10.1007/s00223-026-01572-0},
url = {https://doi.org/10.1007/s00223-026-01572-0}
}RIS
TY - JOUR TI - Cardiovascular Safety of Romosozumab Versus Other Anti-Osteoporosis Medications in Patients with Osteoporosis: A Nationwide Health Insurance Claims Database Study in Japan AU - Yuki Fujita AU - Katsuyasu Kouda AU - Kenji Fujimori AU - Nobukazu Okimoto AU - Shinichi Nakatoh AU - Junko Tamaki AU - Shigeyuki Ishii AU - Sumito Ogawa AU - Masayuki Iki PY - 2026 JO - Calcified Tissue International DO - 10.1007/s00223-026-01572-0 UR - https://doi.org/10.1007/s00223-026-01572-0 ER -
APA
Fujita, Y., Kouda, K., Fujimori, K., Okimoto, N., Nakatoh, S., Tamaki, J., Ishii, S., Ogawa, S., & Iki, M. (2026). Cardiovascular Safety of Romosozumab Versus Other Anti-Osteoporosis Medications in Patients with Osteoporosis: A Nationwide Health Insurance Claims Database Study in Japan. Calcified Tissue International. https://doi.org/10.1007/s00223-026-01572-0
Source records
- crossref · retrieved 2026-09-27T14:38:51.193Z